| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 5.425 | 23.149 | 24.328 | 26.054 | 19.882 |
| Total Income - EUR | - | - | - | - | - | 5.425 | 23.149 | 24.328 | 26.054 | 19.882 |
| Total Expenses - EUR | - | - | - | - | - | 0 | 282 | 618 | 2.740 | 1.781 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 5.425 | 22.867 | 23.710 | 23.314 | 18.101 |
| Net Profit/Loss - EUR | - | - | - | - | - | 5.261 | 22.173 | 22.980 | 19.578 | 15.205 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gynternemed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 466 |
| Current Assets | - | - | - | - | - | 5.466 | 22.472 | 23.411 | 21.863 | 19.962 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 17.970 | 18.431 | 15.295 | 15.131 |
| Cash | - | - | - | - | - | 5.466 | 4.502 | 4.980 | 6.567 | 4.830 |
| Shareholders Funds | - | - | - | - | - | 5.302 | 22.213 | 23.021 | 19.618 | 18.465 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 164 | 259 | 390 | 2.244 | 1.963 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynternemed S.r.l.